Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 17,297 | 10,797 | 8,182 | 12,340 | 8,517 |
| Operating Income | -17,297 | -10,797 | -8,182 | -12,340 | -8,517 |
| Interest Expense | 678 | 1,100 | 542 | 490 | 0 |
| Other Income | 230 | 1,018 | -58 | -419 | -920 |
| Pre-tax Income | -17,745 | -10,879 | -8,782 | -13,249 | -9,437 |
| Net Income Continuous | -17,745 | -10,879 | -8,782 | -13,249 | -9,437 |
| Net Income | $-17,745 | $-10,879 | $-8,782 | $-13,249 | $-9,437 |
| EPS Basic Total Ops | -4.24 | -2.60 | -2.11 | -3.18 | -2.26 |
| EPS Basic Continuous Ops | -4.24 | -2.61 | -2.11 | -3.18 | -2.26 |
| EPS Diluted Total Ops | -4.24 | -2.60 | -2.11 | -3.18 | -2.26 |
| EPS Diluted Continuous Ops | -4.24 | -2.61 | -2.11 | -3.18 | -2.26 |
| EBITDA(a) | $-17,116 | $-10,518 | $-8,237 | $-11,761 | $-7,690 |